Literature DB >> 23745528

FRAX score in acromegaly: does it tell the whole story?

Jessica Brzana1, Chris G Yedinak, Nadia Hameed, Maria Fleseriu.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23745528     DOI： 10.1111/cen.12262

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  3 in total

Review 1.  Acromegalic osteopathy.

Authors:  G Mazziotti; F Maffezzoni; S Frara; A Giustina
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

2.  Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly.

Authors:  Sabrina Chiloiro; Gherardo Mazziotti; Antonella Giampietro; Antonio Bianchi; Stefano Frara; Marilda Mormando; Alfredo Pontecorvi; Andrea Giustina; Laura De Marinis
Journal:  Pituitary       Date:  2018-06       Impact factor: 4.107

Review 3.  [Diagnostics and treatment of acromegaly : Necessity for targeted monitoring of comorbidities].

Authors:  S Petersenn; M Christ-Crain; M Droste; R Finke; J Flitsch; I Kreitschmann-Andermahr; A Luger; J Schopohl; G Stalla
Journal:  Internist (Berl)       Date:  2017-11       Impact factor: 0.743
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.